Trials / Completed
CompletedNCT03831282
Feasibility and Performance Evaluation of INVSENSOR00024
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Accepted
Summary
This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the INVSENSOR00024 sensors in the neonatal population in a clinical environment using convenience sampling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RD SET Neo SpO2 | All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor. |
Timeline
- Start date
- 2019-02-08
- Primary completion
- 2019-05-28
- Completion
- 2019-05-28
- First posted
- 2019-02-05
- Last updated
- 2020-02-25
- Results posted
- 2020-02-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03831282. Inclusion in this directory is not an endorsement.